openPR Logo
Press release

Neurological Biomarkers Market Analysis Current Landscape and Future Outlook

04-10-2025 03:06 PM CET | Health & Medicine

Press release from: Orion Market Research

Neurological Biomarkers Market

Neurological Biomarkers Market

In 2023, the global neurological biomarkers market was valued at approximately USD 7.39 billion. Projections indicate that the market will reach around USD 24.83 billion by 2032, reflecting a compound annual growth rate (CAGR) of 13.0% from 2023 to 2032.

Request a sample copy of this report at: https://www.omrglobal.com/request-sample/neurological-biomarkers-market

Neurological Biomarkers Market Overview:

The global neurological biomarkers market is experiencing substantial growth, driven by the increasing prevalence of neurological disorders such as Alzheimer's and Parkinson's diseases. In 2024, the market was valued at approximately USD 9.45 billion and is projected to reach around USD 31.82 billion by 2034, reflecting a compound annual growth rate (CAGR) of 12.91% during the forecast period. This expansion is attributed to advancements in biomarker research and development, which have enhanced diagnostic accuracy and facilitated early disease detection.

Neurological Biomarkers Market Growth Factors:

Several factors contribute to the growth of the neurological biomarkers market. The rising incidence of neurological disorders has heightened the demand for precise diagnostic tools, prompting increased investment in biomarker research. Technological innovations, particularly in genomics and proteomics, have improved the identification and validation of biomarkers, leading to more effective diagnostic and therapeutic strategies. Additionally, supportive government initiatives and funding for neurological research have accelerated the development and commercialization of novel biomarkers.

◘ The report further explores the key business players along with their in-depth profiling

Thermo Fisher Scientific Inc., QIAGEN N.V., Agilent Technologies, Bio-Rad Laboratories, Quanterix Corporation, Banyan Biomarkers Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., bioMérieux S.A., and BGI Genomics.

Neurological Biomarkers Market Segments:
◘ By Type: Imaging, Blood-Based, Genetic Markers
◘ By Application: Alzheimer's, Parkinson's, Stroke Diagnosis

Neurological Biomarkers Market Drivers & Trends Analysis:

Key drivers in the neurological biomarkers market include the shift towards personalized medicine, which emphasizes tailored treatment plans based on individual biomarker profiles. The integration of artificial intelligence and machine learning in biomarker analysis has enhanced predictive accuracy and streamlined data interpretation. Emerging trends involve the development of minimally invasive and cost-effective biomarker detection methods, such as blood-based assays, which offer greater patient compliance and accessibility. Furthermore, strategic collaborations between pharmaceutical companies and research institutions are fostering innovation and expanding the application of biomarkers in drug development and clinical trials.

If you have any special requirements, Request customization: https://www.omrglobal.com/report-customization/neurological-biomarkers-market

Regional Outlook:

The following section of the report offers valuable insights into different regions and the key players operating within each of them. To assess the growth of a specific region or country, economic, social, environmental, technological, and political factors have been carefully considered. The section also provides readers with revenue and sales data for each region and country, gathered through comprehensive research. This information is intended to assist readers in determining the potential value of an investment in a particular region.

» North America (U.S., Canada, Mexico)
» Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
» Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
» South America (Brazil, Argentina, Rest of SA)
» Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)

Key Benefits for Stakeholders:

⏩ The study represents a quantitative analysis of the present Neurological Biomarkers Market trends, estimations, and dynamics of the market size from 2025 to 2032 to determine the most promising opportunities.
⏩ Porter's five forces study emphasizes the importance of buyers and suppliers in assisting stakeholders to make profitable business decisions and expand their supplier-buyer network.
⏩ In-depth analysis, as well as the market size and segmentation, help you identify current Neurological Biomarkers Market opportunities.
⏩ The largest countries in each region are mapped according to their revenue contribution to the market.
⏩ The Neurological Biomarkers Market research report gives a thorough analysis of the current status of the Neurological Biomarkers Market's major players.

Key questions answered in the report:

➧ What will the market development pace of the Neurological Biomarkers Market?
➧ What are the key factors driving the Neurological Biomarkers Market?
➧ Who are the key manufacturers in the market space?
➧ What are the market openings, market hazards,s and market outline of the Neurological Biomarkers Market?
➧ What are the sales, revenue, and price analysis of the top manufacturers of the Neurological Biomarkers Market?
➧ Who are the distributors, traders, and dealers of Neurological Biomarkers Market?
➧ What are the market opportunities and threats faced by the vendors in the Neurological Biomarkers Market?
➧ What are deals, income, and value examination by types and utilizations of the Neurological Biomarkers Market?
➧ What are deals, income, and value examination by areas of enterprises in the Neurological Biomarkers Market?

Purchase Now Up to 25% Discount on This Premium Report: https://www.omrglobal.com/buy-now/neurological-biomarkers-market?license_type=license-single-user

Reasons To Buy The Neurological Biomarkers Market Report:
➼ In-depth analysis of the market on the global and regional levels.
➼ Major changes in market dynamics and competitive landscape.
➼ Segmentation on the basis of type, application, geography, and others.
➼ Historical and future market research in terms of size, share growth, volume, and sales.
➼ Major changes and assessment in market dynamics and developments.
➼ Emerging key segments and regions
➼ Key business strategies by major market players and their key methods

Contact Us:
Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Website: www.omrglobal.com
Follow Us: LinkedIn | Twitter

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurological Biomarkers Market Analysis Current Landscape and Future Outlook here

News-ID: 3965650 • Views:

More Releases from Orion Market Research

Sales Enablement Software Market Comprehensive Research Study, Business Overview and Regional Forecast to 2032
Sales Enablement Software Market Comprehensive Research Study, Business Overview …
The global Sales Enablement Software Market was valued at approximately USD 3.18 billion in 2023 and is projected to reach around USD 11.5 billion by 2032, growing at a compound annual growth rate (CAGR) of about 15.33% from 2024 to 2032. Sales Enablement Software Market Overview The Sales Enablement Software Market is experiencing significant growth, driven by the increasing demand for tools that enhance sales productivity and effectiveness. These platforms
Cloud Native Applications Market By Application Analysis, Regional Outlook, Competitive Strategies And Forecast 2032
Cloud Native Applications Market By Application Analysis, Regional Outlook, Comp …
The global Cloud Native Applications Market was valued at approximately USD 7.95 billion in 2023 and is projected to reach around USD 259.03 billion by 2032, growing at a compound annual growth rate (CAGR) of about 48.0% from 2024 to 2032. Cloud Native Applications Market Overview The Cloud Native Applications Market is experiencing exponential growth, driven by the increasing demand for scalable, resilient, and agile software solutions across various
Solar Tracker Market Development, Industry Trends, Demand and Growth Analysis and Forecasts 2032
Solar Tracker Market Development, Industry Trends, Demand and Growth Analysis an …
The global Solar Tracker Market was valued at approximately USD 7.88 billion in 2023 and is projected to reach around USD 25.24 billion by 2032, growing at a compound annual growth rate (CAGR) of about 14.3% from 2024 to 2032. Solar Tracker Market Overview The Solar Tracker Market is experiencing significant growth, driven by the increasing adoption of solar energy solutions across various applications. Solar trackers play a crucial role
Diagnostic Imaging Services Market Size Future Scope, Demands and Projected Industry Growths to 2032
Diagnostic Imaging Services Market Size Future Scope, Demands and Projected Indu …
The global Diagnostic Imaging Services Market was valued at approximately USD 530.7 billion in 2023 and is projected to reach around USD 1,218.16 billion by 2032, growing at a compound annual growth rate (CAGR) of about 5.6% from 2024 to 2032. Diagnostic Imaging Services Market Overview The Diagnostic Imaging Services Market is experiencing steady growth, driven by the increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological

All 5 Releases


More Releases for Biomarkers

Predisposition Biomarkers Market - Rapid Growth at Deep Value Price from 2020-20 …
"The new report has been added by qyresearch.com to provide detailed insight into the global Predisposition Biomarkers market. The study will help to get a better understanding about the Predisposition Biomarkers industry competitors, a channel for the distribution, Predisposition Biomarkers growth potential, potentially disruptive trends, Predisposition Biomarkers industry product innovations, market size value/volume (regional/country level, Predisposition Biomarkers industry segments), market share of top players/products. Due to the pandemic, we have included
3rd World Biomarkers Summit
We cordially invite you to the 3rd World Biomarkers Summit to be held at Rome, Italy on April 22-23, 2020. The 2020 edition of the Biomarkers conference will move forward with the theme “Biomarker as a future protagonist”. Biomarkers 2020 concentrates on procuring emerging researches in the sector of medicine and health brought to us via applications of biomarkers. Scientists, Young researchers, pharmaceutical industrialists and medical professionals are expected to
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Global Companion Diagnostic Cancer Biomarkers Market by types (Protein Biomarker …
Global Companion Diagnostic Cancer Biomarkers Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. The report, titled Companion Diagnostic Cancer Biomarkers presents an in-depth study of the Companion Diagnostic Cancer Biomarkers market. Providing a brief history about the market, the report analyses the entire value chain of the market and points out the key drivers and restraints affecting the growth of the market during the forecast period. The report
Global Biomarkers Market Propelled by Growing Usage of Biomarkers in Medical Are …
A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions and help
Biomarkers Summit
SMi present their 4th annual conference on Biomarkers Summit Monday 31st January & Tuesday 1st February 2011 Crowne Plaza The-City, London, UK Don’t Miss Out - Visit to register your place today http://www.smi-online.co.uk/preclinical-biomarkers.asp Sponsored by Caprotec Cell Signalling Technology GVK Bio Selventa Millipore Quest Diagnostics RBM SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out